Amgen wins Enbrel patent protections — for now

Amgen has fought off a patent challenge from Novartis to its blockbuster anti-inflammatory, Enbrel.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Enbrel | Pharmaceuticals